All lobbying filings

Arentfox Schiff LLP

Arentfox Schiff LLP filed a Q2 report for Pharvaris, Inc. on July 18, 2026, reporting $40,000 in lobbying income.

Lobbying for Pharvaris, Inc. · Late-stage biopharmaceutical company

As filed: ARENTFOX SCHIFF LLP for PHARVARIS, INC.

All filings by Arentfox Schiff LLP · Everything Pharvaris, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 18, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Advocacy of policies, legislation and coverage of new pharmaceuticals in the orphan drug space.

Pharmacy

Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.